Startups
Edit
FLX Bio
https://www.flxbio.com/Last activity: 21.07.2020
Active - Reference to RAPT THERAPEUTICS
FLX Bio is a biopharmaceutical company focused on the development of oral small-molecule drugs to activate the immune system against cancer.
Overview
Total raised
$110M
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Apr 29, 2016 | Series B round | $50M |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 22, 2017 | Term Sheet — Friday, December 22 | THREE THINGS Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop SEQUOIA UPDATE: We have more details on Sequoia Capital’s rumored mega-fund. While still in the early stages, the firm’s third glo... |
| Dec 21, 2017 | FLX Bio Raises $60M Series C from Celgene | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--FLX Bio, Inc., a biopharmaceutical company focused on the discovery and development of oral small-molecule drugs to activate the immune system against cancer, today announced the completion of a... |
| Dec 21, 2017 | FLX Bio Completes $60M Series C Financing | FLX Bio, Inc., a South San Francisco, Calif. – based biopharmaceutical company focused on the discovery and development of oral small-molecule drugs to activate the immune system against cancer, completed a $60m Series C financing. Backers ... |
| Dec 21, 2017 | FLX Bio Announces $60M Series C Round | SOUTH SAN FRANCISCO, CA, FLX Bio today announced the completion of a $60 million Series C private financing. >> Click here for more funding data on FLX Bio >> To export FLX Bio funding data to PDF and Excel, click here FL... |
| Apr 29, 2016 | FLX Bio Raises $50M in Series B Funding | FLX Bio, Inc., a South San Francisco, CA-based biopharmaceutical company focused on the discovery and development of novel cancer immunotherapies, raised $50m in Series B funding. Backers included The Column Group (TCG), Topspin Partners, K... |
Reviews 0
FAQ about FLX Bio
How much funding has FLX Bio raised?
FLX Bio has raised $110M in total across 2 funding rounds.
What funding rounds has FLX Bio raised?
Parsers VC lists 2 funding rounds of FLX Bio, among them a Series B round of $50M on Apr 29, 2016.
What has the press written about FLX Bio?
Parsers VC has collected 6 articles mentioning FLX Bio, among them “Term Sheet — Friday, December 22” (Dec 22, 2017) and “FLX Bio Raises $60M Series C from Celgene” (Dec 21, 2017).
Is FLX Bio still active?
Yes, FLX Bio is active; its latest activity on Parsers VC dates from Jul 21, 2020.